Renata Veselska

11PUBLICATIONS
21CO-AUTHORS
Molecular targetsPredictive and prognostic markersMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 04, 2024
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits.

Lucie Curylova, Iva Staniczkova Zambo, Jakub Neradil

|Aug 12, 2022
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors.

Silvia Paukovcekova, Maria Krchniakova, Petr Chlapek

|Jan 11, 2022
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma.

Peter Macsek, Jan Skoda, Maria Krchniakova

|Oct 25, 2021
Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.

Andrew D Woods, Noah E Berlow, Michael V Ortiz

|Jul 24, 2021
New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling.

Michal Mahdal, Jakub Neradil, Peter Mudry

|Dec 18, 2020
Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms.

Silvia Paukovcekova, Jan Skoda, Jakub Neradil

Pageof 2

Frequent Collaborators

6 joint publications

Jakub Neradil

5 joint publications

Jan Skoda

3 joint publications

Maria Krchniakova

2 joint publications

Iva Staniczkova Zambo